Analysts: Cubist Pharmaceuticals Inc (CBST.OQ)

CBST.OQ on NASDAQ Stock Exchange Global Select Market

62.51USD
4:00pm EDT
Price Change (% chg)

$-0.14 (-0.22%)
Prev Close
$62.65
Open
$62.42
Day's High
$63.23
Day's Low
$61.80
Volume
515,725
Avg. Vol
258,049
52-wk High
$82.12
52-wk Low
$53.14

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.10 December 25 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 5
(2) OUTPERFORM 7 8 7 7
(3) HOLD 6 5 5 6
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.06 2.00 2.00 2.06

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 16 307.32 326.69 283.60 288.57
Quarter Ending Dec-14 16 336.97 362.40 305.20 301.55
Year Ending Dec-14 19 1,201.85 1,254.26 1,144.40 1,136.42
Year Ending Dec-15 19 1,421.92 1,629.86 1,304.00 1,279.25
Earnings (per share)
Quarter Ending Sep-14 12 0.10 0.38 -0.15 0.53
Quarter Ending Dec-14 12 0.18 0.44 -0.20 0.58
Year Ending Dec-14 13 0.80 1.39 0.30 1.69
Year Ending Dec-15 14 1.53 3.75 0.60 2.56
LT Growth Rate (%) 2 24.50 29.00 20.00 25.43

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 299.60 294.40 5.20 1.74
Quarter Ending Mar-14 285.24 261.23 24.01 8.42
Quarter Ending Dec-13 282.73 299.74 17.01 6.02
Quarter Ending Sep-13 268.83 265.99 2.84 1.06
Quarter Ending Jun-13 254.73 258.78 4.05 1.59
Earnings (per share)
Quarter Ending Jun-14 0.02 0.30 0.28 1,763.35
Quarter Ending Mar-14 -0.02 0.30 0.32 -1,314.57
Quarter Ending Dec-13 -0.01 0.20 0.21 -3,873.58
Quarter Ending Sep-13 0.35 0.26 0.09 24.66
Quarter Ending Jun-13 0.38 0.35 0.03 8.93

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 307.32 313.10 312.36 312.36 288.57
Quarter Ending Dec-14 336.97 343.17 343.00 342.96 301.55
Year Ending Dec-14 1,201.85 1,218.02 1,217.86 1,218.37 1,136.42
Year Ending Dec-15 1,421.92 1,456.01 1,456.46 1,455.99 1,279.25
Earnings (per share)
Quarter Ending Sep-14 0.10 0.05 0.04 0.04 0.53
Quarter Ending Dec-14 0.18 0.12 0.11 0.11 0.58
Year Ending Dec-14 0.80 0.51 0.50 0.50 1.69
Year Ending Dec-15 1.53 1.79 1.87 1.87 2.56

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 1 13 1 13
Quarter Ending Dec-14 3 12 4 11
Year Ending Dec-14 2 13 2 13
Year Ending Dec-15 1 12 1 12
Earnings
Quarter Ending Sep-14 6 4 6 3
Quarter Ending Dec-14 4 5 4 4
Year Ending Dec-14 9 1 8 1
Year Ending Dec-15 1 8 1 9

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Factual Report
$150.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks